Curaleaf Holdings (CURLF) Change in Cash (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Change in Cash of $15.4 million for Q4 2024, up 164.45% year-over-year from $5.8 million in Q1 2024, and up 531.2% quarter-over-quarter from $2.4 million in Q3 2024.
Curaleaf Holdings (CURLF) Change in Cash (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Change in Cash history runs 6 years deep, the most recent figure standing at $15.4 million for Q4 2024.
- In Q4 2024, Change in Cash rose 164.45% year-over-year to $15.4 million; the TTM figure through Dec 2024 stood at $15.6 million (up 122.08% YoY), while the FY2025 annual figure was -$6.1 million, down 139.41% from the prior year.
- Change in Cash for Q4 2024 stood at $15.4 million, up from $2.4 million in the prior quarter.
- The five-year high for Change in Cash was $60.8 billion in Q1 2024, with the low at -$60.8 billion in Q2 2024.
- The 5-year median for Change in Cash is -$2.0 million (2020), against an average of $5.8 million.
- The sharpest annual moves came in 2021 and 2023: Change in Cash slumped 39524.71% in 2021, then jumped 13603.14% in 2023.
- Curaleaf Holdings' Change in Cash stood at -$4.1 million in 2020, then slumped by 355.73% to -$18.7 million in 2021, then slumped by 83.68% to -$34.4 million in 2022, then jumped by 30.52% to -$23.9 million in 2023, then soared by 164.45% to $15.4 million in 2024.
- Business Quant data shows CURLF's Change in Cash at $15.4 million in Q4 2024, $2.4 million in Q3 2024, and -$60.8 billion in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 15.40 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | -60.76 Bn |
| Mar 31, 2024 | 60.76 Bn |
| Dec 31, 2023 | -23.89 Mn |
| Sep 30, 2023 | 31.71 Mn |
| Jun 30, 2023 | 47.40 Bn |
| Mar 31, 2023 | -47.48 Bn |
| Dec 31, 2022 | -34.38 Mn |
| Sep 30, 2022 | 11.16 Mn |
| Jun 30, 2022 | -351.06 Mn |
| Mar 31, 2022 | 242.60 Mn |
| Dec 31, 2021 | -18.72 Mn |
| Sep 30, 2021 | -14.60 Mn |
| Jun 30, 2021 | -54.41 Mn |
| Mar 31, 2021 | 314.59 Mn |
| Dec 31, 2020 | -4.11 Mn |
| Sep 30, 2020 | 37,025.00 |
| Jun 30, 2020 | -53.59 Mn |
| Mar 31, 2020 | 134.05 Mn |